D. E. Shaw & Co., Inc. BIOSPECIFICS TECHNOLOGIES CO Transaction History

D. E. Shaw & Co., Inc.

  • $107 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
N/A
-4,869 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
N/A
-500 Reduced 9.31%
4,869 $298,000
Q1 2020

May 15, 2020
SELL
N/A
-1,400 Reduced 20.68%
5,369 $304,000
Q2 2019

Aug 14, 2019
BUY
N/A
3,319 Added 96.2%
6,769 $404,000
Q1 2019

May 15, 2019
SELL
N/A
-4,354 Reduced 55.79%
3,450 $215,000
Q4 2018

Feb 14, 2019
SELL
N/A
-4,257 Reduced 35.3%
7,804 $473,000
Q3 2018

Nov 14, 2018
SELL
N/A
-540 Reduced 4.29%
12,061 $705,000
Q2 2018

Aug 14, 2018
BUY
N/A
2,165 Added 20.75%
12,601 $565,000
Q1 2018

May 15, 2018
BUY
N/A
900 Added 9.44%
10,436 $463,000
Q4 2017

Feb 14, 2018
BUY
N/A
4,005 Added 72.41%
9,536 $413,000
Q3 2017

Nov 14, 2017
BUY
N/A
5,531
5,531 $257,000
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email